Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 AB INBEV ABI Aug 18, 2022 52.68 -0.66   
 Ackermans & van Haaren NV ACKB Aug 18, 2022 144.80 +0.28   
 Aedifica SA AED Aug 18, 2022 102.00 +0.99   
 Ageas AGS Aug 18, 2022 42.89 -1.40   
 APERAM APAM Aug 18, 2022 30.77 -0.23   
 Argen X SE ARGX Aug 18, 2022 374.90 -0.53   
 Barco NV BAR Aug 18, 2022 24.68 +0.82   
 Bel20 BEL20 Aug 18, 2022 3 804.09 -0.43   
 Cofinimmo COFB Aug 18, 2022 108.90 +0.18   
 Colruyt SA COLR Aug 18, 2022 27.94 +0.47   
 GALAPAGOS GLPG Aug 18, 2022 52.24 -1.36   
 Groupe Bruxelles Lambert SA GBLB Aug 18, 2022 80.70 +0.05   
 ING GROEP N.V. INGA Aug 18, 2022 9.27 -0.16   
 KBC Groep NV KBC Aug 18, 2022 50.24 -3.31   
 Proximus SADP PROX Aug 18, 2022 13.49 +0.45   
 Sofina SA SOF Aug 18, 2022 221.40 -0.72   
 Solvay SA SOLB Aug 18, 2022 84.72 +0.52   
 Telenet Group Holding NV TNET Aug 18, 2022 15.23 +0.07   
 UCB SA UCB Aug 18, 2022 72.62 +0.25   
 Umicore SA UMI Aug 18, 2022 34.74 +0.84   
 Warehousing & Distribution De Pauw WDP Aug 18, 2022 33.76 +1.63   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+